The Discounted Cash Flow (DCF) valuation of Arena Pharmaceuticals Inc (ARNA) is (140,813,979,889.72) USD. With the latest stock price at 99.99 USD, the upside of Arena Pharmaceuticals Inc based on DCF is -140828062796.0%.
Based on the latest price of 99.99 USD and our DCF valuation, Arena Pharmaceuticals Inc (ARNA) is a sell. selling ARNA stocks now will result in a potential gain of 140828062796.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.3% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (464,371,658,821.82) - (82,686,553,525.36) | (140,813,979,889.72) |
| Upside | -464418100731.9% - -82694823107.7% | -140828062796.0% |